Skip to content

Effect of Althaea rosea batching on bilirubin levels of neonates with hyperbilirubinemia

Effect of Althaea rosea batching on bilirubin levels of neonates with hyperbilirubinemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210526051411N1
Enrollment
60
Registered
2021-12-11
Start date
2021-06-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

jaundice. Unspecified jaundice

Interventions

Intervention 1: For the intervention group, grind 5 grams of Althaea officinalis and put it in one liter of cold water for 8 hours, then take the flower extract with a strainer and then take the extra

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 10 Days

Inclusion criteria

Inclusion criteria: Jaundice based on the doctor's diagnosis and serum total bilirubin 13 mg / dL and above Do not suffer from underlying diseases Total serum bilirubin 16 mg per deciliter and above No ABO or RH incompatibility, no G6PD enzyme disorder and no positive Coombs test Absence of physical abnormalities in physical examination Does not have any risk factors such as hemolysis, sepsis, asphyxia No history of skin allergies in family members or any allergies to marshmallows Term baby (over 38 weeks) Weight over 2500 kg

Exclusion criteria

Exclusion criteria: Increased jaundice that requires blood transfusion Withdrawal of the baby's parents to continue participating in the research Discharge or death of the infant before the end of the intervention period The baby becomes ill during the course of the disease and during the study, which for any reason contradicts the intervention.

Design outcomes

Primary

MeasureTime frame
Bilirubin level. Timepoint: Before and after the study. Method of measurement: Photometry (by Juandice method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Rahimi

Rafsanjan University of Medical Sciences

neda.rahimi90@yahoo.com34255900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026